Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline

Danielle N. Margalit; Christopher J. Anker; Michalis Aristophanous; Musaddiq Awan; Gopal K. Bajaj; Lisa Bradfield; Joseph Califano; Jimmy J. Caudell; Christina Chapman; Adam S. Garden; Paul M. Harari; Amanda Helms; Alexander J. Lin; Ellie Maghami; Ranee Mehra; L M Parker; Yelizaveta Shnayder; Sharon Spencer; Paul Swiecicki; Jillian Tsai; David J. Sher

doi:10.1016/j.prro.2024.05.007

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Human Papilloma Virus (HPV)-associated oropharyngeal squamous cell carcinoma (OPSCC) is a distinct disease from other head and neck tumors. This guideline provides evidence-based recommendations on the critical decisions in its curative treatment, including both definitive and postoperative radiation therapy (RT) management.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Margalit et al. (2024) studied this question.

synapsesocial.com/papers/68e642a9b6db6435875d4a98 https://doi.org/10.1016/j.prro.2024.05.007

View Full Paper

Ask AI

Bookmark

Share

Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline

Ask about this paper

Abstract

Discussion

Cite This Study

Radiation Therapy for HPV-Positive Oropharyngeal Squamous Cell Carcinoma: An ASTRO Clinical Practice Guideline

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading